Citation: Fatemeh HAGHIGHI, Ali MORSALI, Mohammad Reza BOZORGMEHR, S. Ali BEYRAMABADI. Quantum Chemical Studies of Host-guest Nanostructures of PAMAM Dendrimers in Drug Deliver[J]. Chinese Journal of Structural Chemistry, ;2020, 39(5): 838-848. doi: 10.14102/j.cnki.0254–5861.2011–2510 shu

Quantum Chemical Studies of Host-guest Nanostructures of PAMAM Dendrimers in Drug Deliver

a.
Department of Chemistry, Mashhad Branch, Islamic Azad University, Mashhad, Iran
b.
Research Center for Animal Development Applied Biology, Mashhad Branch, Islamic Azad University, Mashhad 917568, Iran

Corresponding author: Ali MORSALI, almorsali@yahoo.com; morsali@mshdiau.ac.iraa
Received Date: 24 June 2019
Accepted Date: 6 January 2020

Figures(5)

Using B3LYP and M06-2X functionals, eight noncovalent configurations for the adsorption of D-penicillamine drug (DPA) drug on poly(amidoamine) G0 generation dendrimer (PAMAMG0) carrier have been investigated. The quantum molecular descriptors and the binding and solvation energies were examined in aqueous solution and gas phase. The binding energies demonstrated the energetic stability of non-bonded species (PAMAMG0/DPA1-8). The solvation energies showed that solubility of DPA rises in the vicinity of PAMAMG0 carrier which is a fundamental factor for applicability of a carrier. Considering quantum molecular descriptors such as electrophilicity power and global hardness, the toxicity of DPA drug in the vicinity of PAMAMG0 carrier decreases and drug release is facilitated. The AIM analysis for all PAMAMG0/DPA1-8 structures indicated that the hydrogen and pseudo-hydrogen bonds play important roles in the functionalization of PAMAMG0 with DPA drug. The configuration in which DPA drug interacts simultaneously with two -NH₂ functional groups of PAMAMG0 is the most stable configuration.
- DFT,
- D-penicillamine,
- hydrogen bonding,
- nanomedicine,
- poly(amidoamine) dendrimer
1. [1]
  Chauhan, A. S. Dendrimers for drug delivery. Molecules 2018, 23, 938–947. doi: 10.3390/molecules23040938
2. [2]
  Marasini, N.; Haque, S.; Kaminskas, L. M. Polymer-drug conjugates as inhalable drug delivery systems: a review. Curr. Opin. Colloid Interface Sci. 2017, 31, 18−29. doi: 10.1016/j.cocis.2017.06.003
3. [3]
  Pattni, B. S.; Chupin, V. V.; Torchilin, V. P. New developments in liposomal drug delivery. Chem. Rev. 2015, 115, 10938−10966. doi: 10.1021/acs.chemrev.5b00046
4. [4]
  Raza, K.; Thotakura, N.; Kumar, P.; Joshi, M.; Bhushan, S.; Bhatia, A.; Kumar, V.; Malik, R.; Sharma, G.; Guru, S. K. C60-fullerenes for delivery of docetaxel to breast cancer cells: a promising approach for enhanced efficacy and better pharmacokinetic profile. Int. J. Pharm. 2015, 495, 551−559. doi: 10.1016/j.ijpharm.2015.09.016
5. [5]
  Meysam, N. Antioxidant activity of sesamol derivatives and their drug delivery via C60 nanocage: a theoretical study. Chin. J. Struct. Chem. 2019, 38, 195−200.
6. [6]
  Spencer, D. S.; Puranik, A. S.; Peppas, N. A. Intelligent nanoparticles for advanced drug delivery in cancer treatment. Curr. Opin. Chem. Eng. 2015, 7, 84−92. doi: 10.1016/j.coche.2014.12.003
7. [7]
  Khorram, R.; Morsali, A.; Raissi, H.; Hakimi, M.; Beyramabadi, S. A. Mechanistic, energetic and structural aspects of the adsorption of carmustine on the functionalized carbon nanotubes. Chin. J. Struc. Chem. 2017, 36, 1639−1646.
8. [8]
  Kamel, M.; Raissi, H.; Morsali, A.; Shahabi, M. Assessment of the adsorption mechanism of flutamide anticancer drug on the functionalized single-walled carbon nanotube surface as a drug delivery vehicle: an alternative theoretical approach based on DFT and MD. Appl. Surf. Sci. 2018, 434, 492−503. doi: 10.1016/j.apsusc.2017.10.165
9. [9]
  Lotfi, M.; Morsali, A.; Bozorgmehr, M. R. Comprehensive quantum chemical insight into the mechanistic understanding of the surface functionalization of carbon nanotube as a nanocarrier with cladribine anticancer drug. Appl. Surf. Sci. 2018, 462, 720−729. doi: 10.1016/j.apsusc.2018.08.151
10. [10]
  Hamedani, S.; Moradi, S.; Aghaie, H. Adsorption of folic acid on the single-walled carbon nanotubes: AIM and NBO analyses via DFT. Chin. J. Struc. Chem. 2015, 34, 1161−1169.
11. [11]
  Jansen, J. F.; Meijer, E.; de Brabander-van den Berg, E. M. The dendritic box: shape-selective liberation of encapsulated guests. J. Am. Chem. Soc. 1995, 117, 4417−4418. doi: 10.1021/ja00120a032
12. [12]
  Zimmerman, S. C.; Zeng, F.; Reichert, D. E.; Kolotuchin, S. V. Self-assembling dendrimers. Science 1996, 271, 1095−1098. doi: 10.1126/science.271.5252.1095
13. [13]
  Tomalia, D. A.; Baker, H.; Dewald, J.; Hall, M.; Kallos, G.; Martin, S.; Roeck, J.; Ryder, J.; Smith, P. A new class of polymers: starburst-dendritic macromolecules. Polym. J. 1985, 17, 117−132. doi: 10.1295/polymj.17.117
14. [14]
  Tomalia, D. A.; Naylor, A. M.; Goddard Ⅲ, W. A. Starburst dendrimers: molecular‐level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew. Chem. Int. Ed. Engl. 1990, 29, 138−175. doi: 10.1002/anie.199001381
15. [15]
  Huang, D.; Wu, D. Biodegradable dendrimers for drug delivery. Mater. Sci. Eng.: C 2018, 90, 713−727.
16. [16]
  Svenson, S.; Tomalia, D. A. Dendrimers in biomedical applications-reflections on the field. Adv. Drug Deliv. Rev. 2012, 64, 102−115. doi: 10.1016/j.addr.2012.09.030
17. [17]
  Frechet, J. M. Functional polymers and dendrimers: reactivity, molecular architecture, and interfacial energy. Science 1994, 263, 1710−1715. doi: 10.1126/science.8134834
18. [18]
  Hawker, C. J.; Frechet, J. M. Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic acromolecules. J. Am. Chem. Soc. 1990, 112, 7638−7647. doi: 10.1021/ja00177a027
19. [19]
  Miller, T. M.; Neenan, T. X. Convergent synthesis of monodisperse dendrimers based upon 1, 3, 5-trisubstituted benzenes. Chem. Mater. 1990, 2, 346−349. doi: 10.1021/cm00010a006
20. [20]
  Chen, C. Z.; Cooper, S. L. Interactions between dendrimer biocides and bacterial membranes. Biomaterials 2002, 23, 3359−3368. doi: 10.1016/S0142-9612(02)00036-4
21. [21]
  Kukowska-Latallo, J. F.; Bielinska, A. U.; Johnson, J.; Spindler, R.; Tomalia, D. A.; Baker, J. R. Efficient transfer of genetic material into mammalian cells using starburst polyamidoamine dendrimers. Proc. Natl. Acad. Sci. 1996, 93, 4897−4902. doi: 10.1073/pnas.93.10.4897
22. [22]
  Kaanumalle, L. S.; Nithyanandhan, J.; Pattabiraman, M.; Jayaraman, N.; Ramamurthy, V. Water-soluble dendrimers as photochemical reaction media: chemical behavior of singlet and triplet radical pairs inside dendritic reaction cavities. J. Am. Chem. Soc. 2004, 126, 8999−9006. doi: 10.1021/ja049492w
23. [23]
  Tomalia, D.; Reyna, L.; Svenson, S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem. Soc. Trans. 2007, 35, 61−67. doi: 10.1042/BST0350061
24. [24]
  Kirkpatrick, G. J.; Plumb, J. A.; Sutcliffe, O. B.; Flint, D. J.; Wheate, N. J. Evaluation of anionic half generation 3.5~6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin. J. Inorg. Biochem. 2011, 105, 1115−1122. doi: 10.1016/j.jinorgbio.2011.05.017
25. [25]
  Lim, J.; Simanek, E. E. Triazine dendrimers as drug delivery systems: from synthesis to therapy. Adv. Drug Deliv. Rev. 2012, 64, 826−835. doi: 10.1016/j.addr.2012.03.008
26. [26]
  Neerman, M. F.; Chen, H. T.; Parrish, A. R.; Simanek, E. E. Reduction of drug toxicity using dendrimers based on melamine. Mol. Pharm. 2004, 1, 390−393. doi: 10.1021/mp049957p
27. [27]
  Du, L.; Jin, Y.; Yang, J.; Wang, S.; Wang, X. A functionalized poly(amidoamine)nanocarrier-loading 5-fluorouracil: pH-responsive drug release and enhanced anticancer effect. Anti-cancer Drugs 2013, 24, 172−180. doi: 10.1097/CAD.0b013e32835920fa
28. [28]
  Malik, N.; Evagorou, E. G.; Duncan, R. Dendrimer-platinate: a novel approach to cancer chemotherapy. Anti-cancer Drugs 1999, 10, 767−776. doi: 10.1097/00001813-199909000-00010
29. [29]
  Yellepeddi, V. K.; Kumar, A.; Maher, D. M.; Chauhan, S. C.; Vangara, K. K.; Palakurthi, S. Biotinylated PAMAM dendrimers for intracellular delivery of cisplatin to ovarian cancer: role of SMVT. Anticancer Res. 2011, 31, 897−906.
30. [30]
  Zhu, S.; Hong, M.; Zhang, L.; Tang, G.; Jiang, Y.; Pei, Y. PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation. Pharm. Res. 2010, 27, 161−174. doi: 10.1007/s11095-009-9992-1
31. [31]
  Kono, K.; Kojima, C.; Hayashi, N.; Nishisaka, E.; Kiura, K.; Watarai, S.; Harada, A. Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine)dendrimers bearing adriamycin. Biomaterials 2008, 29, 1664−1675. doi: 10.1016/j.biomaterials.2007.12.017
32. [32]
  Muniswamy, V. J.; Raval, N.; Gondaliya, P.; Tambe, V.; Kalia, K.; Tekade, R. K. 'Dendrimer-cationized-albumin'encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin. Int. J. Pharm. 2019, 555, 77−99. doi: 10.1016/j.ijpharm.2018.11.035
33. [33]
  Gajbhiye, V.; Kumar, P. V.; Tekade, R. K.; Jain, N. PEGylated PPI dendritic architectures for sustained delivery of H₂ receptor antagonist. Eur. J. Med. Chem. 2009, 44, 1155−1166. doi: 10.1016/j.ejmech.2008.06.012
34. [34]
  Majoros, I. J.; Thomas, T. P.; Mehta, C. B.; Baker, J. R. Poly(amidoamine)dendrimer-based multifunctional engineered nanodevice for cancer therapy. J. Med. Chem. 2005, 48, 5892−5899. doi: 10.1021/jm0401863
35. [35]
  Devarakonda, B.; Hill, R. A.; de Villiers, M. M. The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine. Int. J. Pharm. 2004, 284, 133−140. doi: 10.1016/j.ijpharm.2004.07.006
36. [36]
  Lim, J.; Lo, S. T.; Hill, S.; Pavan, G. M.; Sun, X.; Simanek, E. E. Antitumor activity and molecular dynamics simulations of paclitaxel-laden triazine dendrimers. Mol. Pharm. 2012, 9, 404−412. doi: 10.1021/mp2005017
37. [37]
  Xie, Y.; Yao, Y. Incorporation with dendrimer-like biopolymer leads to improved soluble amount and in vitro anticancer efficacy of paclitaxel. J. Pharm. Sci. 2019, 108, 1984−1990. doi: 10.1016/j.xphs.2018.12.026
38. [38]
  Morgan, M. T.; Carnahan, M. A.; Immoos, C. E.; Ribeiro, A. A.; Finkelstein, S.; Lee, S. J.; Grinstaff, M. W. Dendritic molecular capsules for hydrophobic compounds. J. Am. Chem. Soc. 2003, 125, 15485−15489. doi: 10.1021/ja0347383
39. [39]
  Morgan, M. T.; Nakanishi, Y.; Kroll, D. J.; Griset, A. P.; Carnahan, M. A.; Wathier, M.; Oberlies, N. H.; Manikumar, G.; Wani, M. C.; Grinstaff, M. W. Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro. Cancer res. 2006, 66, 11913−11921. doi: 10.1158/0008-5472.CAN-06-2066
40. [40]
  Wang, F.; Bronich, T. K.; Kabanov, A. V.; Rauh, R. D.; Roovers, J. Synthesis and evaluation of a star amphiphilic block copolymer from poly(ε-caprolactone) and poly(ethylene glycol) as a potential drug delivery carrier. Bioconjugate Chem. 2005, 16, 397−405. doi: 10.1021/bc049784m
41. [41]
  Fröhlich, T.; Hahn, F.; Belmudes, L.; Leidenberger, M.; Friedrich, O.; Kappes, B.; Couté, Y.; Marschall, M.; Tsogoeva, S. B. Synthesis of artemisinin‐derived dimers, trimers and dendrimers: investigation of their antimalarial and antiviral activities including putative mechanisms of action. Chem. Eur. J. 2018, 24, 8103−8113. doi: 10.1002/chem.201800729
42. [42]
  Pedro-Hernández, L. D.; Martínez-Klimova, E.; Martínez-Klimov, M. E.; Cortez-Maya, S.; Vargas-Medina, A. C.; Ramírez-Ápan, T.; Hernández-Ortega, S.; Martínez-García, M. Anticancer activity of resorcinarene-PAMAM-dendrimer conjugates of flutamide. Anticancer Agents Med. Chem. 2018, 18, 993−1000. doi: 10.2174/1871520618666171219114532
43. [43]
  Scutaru, A. M.; Wenzel, M.; Scheffler, H.; Wolber, G.; Gust, R. Optimization of the N-lost drugs melphalan and bendamustine: synthesis and cytotoxicity of a new set of dendrimer-drug conjugates as tumor therapeutic agents. Bioconjugate Chem. 2010, 21, 1728−1743. doi: 10.1021/bc900453f
44. [44]
  Soni, N.; Jain, K.; Gupta, U.; Jain, N. Controlled delivery of gemcitabine hydrochloride using mannosylated poly(propyleneimine) dendrimers. J. Nanopart. Res. 2015, 17, 458−465. doi: 10.1007/s11051-015-3265-1
45. [45]
  Nabavizadeh, F.; Fanaei, H.; Imani, A.; Vahedian, J.; Amoli, F. A.; Ghorbi, J.; Sohanaki, H.; Mohammadi, S. M.; Golchoobian, R. Evaluation of nanocarrier targeted drug delivery of capecitabine-pamam dendrimer complex in a mice colorectal cancer model. Acta Med. Iran. 2016, 54, 485−493.
46. [46]
  Neerman, M. F. The efficiency of a PAMAM dendrimer toward the encapsulation of the antileukemic drug 6-mercaptopurine. Anti-cancer Drugs 2007, 18, 839−842. doi: 10.1097/CAD.0b013e32809ef9d0
47. [47]
  Maciel, D.; Guerrero-Beltrán, C.; Ceña-Diez, R.; Tomás, H.; Muñoz-Fernández, M. Á.; Rodrigues, J. New anionic poly(alkylideneamine) dendrimers as microbicide agents against HIV-1 infection. Nanoscale 2019, 11, 9679−9690. doi: 10.1039/C9NR00303G
48. [48]
  Reguera, R.; Rodrigues, J.; Correa, J.; Munoz-Fernandez, M. A. In Phosphorous Dendrimers in Biology and Nanomedicine. Pan Stanford: Singapore 2018, 195−226.
49. [49]
  Guerrero-Beltran, C.; Rodriguez-Izquierdo, I.; Serramia, M. J.; Araya-Duran, I.; Márquez-Miranda, V.; Gomez, R.; de la Mata, F. J.; Leal, M.; González-Nilo, F.; Muñoz-Fernández, M. Á. Anionic carbosilane dendrimers destabilize the GP120-CD4 complex blocking HIV-1 entry and cell to cell fusion. Bioconjugate Chem. 2018, 29, 1584−1594. doi: 10.1021/acs.bioconjchem.8b00106
50. [50]
  Sepúlveda‐Crespo, D.; Ceña‐Díez, R.; Jiménez, J. L.; Ángeles Muñoz‐Fernández, M. Mechanistic studies of viral entry: an overview of dendrimer‐based microbicides as entry inhibitors against both HIV and HSV‐2 overlapped infections. Med. Res. Rev. 2017, 37, 149−179. doi: 10.1002/med.21405
51. [51]
  Aliev, G.; Ashraf, G. M.; Tarasov, V. V.; Chubarev, V. N.; Leszek, J.; Gasiorowski, K.; Makhmutovа, A.; Baeesa, S. S.; Avila-Rodriguez, M.; Ustyugov, A. A. Alzheimer's disease-future therapy based on dendrimers. Curr. Neuropharmacol. 2019, 17, 288−294. doi: 10.2174/1570159X16666180918164623
52. [52]
  Wasiak, T.; Marcinkowska, M.; Pieszynski, I.; Zablocka, M.; Caminade, A. M.; Majoral, J. P.; Klajnert-Maculewicz, B. Cationic phosphorus dendrimers and therapy for Alzheimer's disease. New J. Chem. 2015, 39, 4852−4859. doi: 10.1039/C5NJ00309A
53. [53]
  Klajnert, B.; Cangiotti, M.; Calici, S.; Majoral, J. P.; Caminade, A. M.; Cladera, J.; Bryszewska, M.; Ottaviani, M. F. EPR study of the interactions between dendrimers and peptides involved in Alzheimer's and prion diseases. Macromol. Biosci. 2007, 7, 1065−1074. doi: 10.1002/mabi.200700049
54. [54]
  Solassol, J. M.; Crozet, C.; Perrier, V.; Leclaire, J.; Beranger, F.; Caminade, A. M.; Meunier, B.; Dormont, D.; Majoral, J. P.; Lehmann, S. Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie. J. Gen. Virol. 2004, 85, 791−1799.
55. [55]
  Yiyun, C.; Na, M.; Tongwen, X.; Rongqiang, F.; Xueyuan, W.; Xiaomin, W.; Longping, W. Transdermal delivery of nonsteroidal anti‐inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. J. Pharm. Sci. 2007, 96, 595−602. doi: 10.1002/jps.20745
56. [56]
  Yiyun, C.; Tongwen, X. Dendrimers as potential drug carriers. Part Ⅰ. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers. Eur. J. Med. Chem. 2005, 40, 1188−1192. doi: 10.1016/j.ejmech.2005.06.010
57. [57]
  Bohr, A.; Tsapis, N.; Andreana, I.; Chamarat, A.; Foged, C.; Delomenie, C.; Noiray, M.; El Brahmi, N.; Majoral, J. P.; Mignani, S. Anti-inflammatory effect of anti-TNF-α siRNA cationic phosphorus dendrimer nanocomplexes administered intranasally in a murine acute lung injury model. Biomacromolecules 2017, 18, 2379−2388. doi: 10.1021/acs.biomac.7b00572
58. [58]
  Castonguay, A.; Ladd, E.; van de Ven, T. G.; Kakkar, A. Dendrimers as bactericides. New J. Chem. 2012, 36, 199−204. doi: 10.1039/C1NJ20481E
59. [59]
  Ladd, E.; Sheikhi, A.; Li, N.; van de Ven, T.; Kakkar, A. Design and synthesis of dendrimers with facile surface group functionalization, and an evaluation of their bactericidal efficacy. Molecules 2017, 22, 868−876. doi: 10.3390/molecules22060868
60. [60]
  Heredero-Bermejo, I.; Hernández-Ros, J. M.; Sánchez-García, L.; Maly, M.; Verdú-Expósito, C.; Soliveri, J.; de la Mata, F. J.; Copa-Patiño, J. L.; Pérez-Serrano, J.; Sánchez-Nieves, J. Ammonium and guanidine carbosilane dendrimers and dendrons as microbicides. Eur. Polym. J. 2018, 101, 159−168. doi: 10.1016/j.eurpolymj.2018.02.025
61. [61]
  Tomalia, D. A. In quest of a systematic framework for unifying and defining nanoscience. J. Nanopart. Res. 2009, 11, 1251−1310. doi: 10.1007/s11051-009-9632-z
62. [62]
  Tomalia, D. A. Dendrimer research. Science 1991, 252, 1231−1231. doi: 10.1126/science.252.5010.1231.c
63. [63]
  Saikia, N.; Deka, R. C. Adsorption of isoniazid and pyrazinamide drug molecules onto nitrogen-doped single-wall carbon nanotubes: an ab initio study. Struct. Chem. 2014, 25, 593−605. doi: 10.1007/s11224-013-0327-9
64. [64]
  Chegini, H.; Morsali, A.; Bozorgmehr, M.; Beyramabadi, S. Theoretical study on the mechanism of covalent bonding of dapsone onto functionalised carbon nanotubes: effects of coupling agent. Prog. React. Kinet. Mech. 2016, 41, 345−355. doi: 10.3184/146867816X14716178637309
65. [65]
  Xu, H.; Li, L.; Fan, G.; Chu, X. DFT study of nanotubes as the drug delivery vehicles of Efavirenz. Comput. Theor. Chem. 2018, 1131, 57−68. doi: 10.1016/j.comptc.2018.03.032
66. [66]
  Etebari, N.; Morsali, A.; Beyramabadi, S. A. Structural and mechanistic studies of γ-Fe₂O₃ nanoparticle as capecitabine drug nanocarrier. Chin. J. Struct. Chem. 2018, 37, 375−382.
67. [67]
  Kamel, M.; Raissi, H.; Morsali, A. Theoretical study of solvent and co-solvent effects on the interaction of flutamide anticancer drug with carbon nanotube as a drug delivery system. J. Mol. Liq. 2017, 248, 490−500. doi: 10.1016/j.molliq.2017.10.078
68. [68]
  Khoshbayan, B.; Morsali, A.; Bozorgmehr, M. R. Structural and electronic properties of cyclic peptide-gold nanoparticle as a drug delivery system. Chin. J. Struc. Chem. 2019, 38, 566−580.
69. [69]
  Shahabi, D.; Tavakol, H. DFT, NBO and molecular docking studies of the adsorption of fluoxetine into and on the surface of simple and sulfur-doped carbon nanotubes. Appl. Surf. Sci. 2017, 420, 267−275. doi: 10.1016/j.apsusc.2017.05.068
70. [70]
  Naderi, S.; Morsali, A.; Bozorgmehr, M. R.; Beyramabadi, S. A. Mechanistic, energetic and structural studies of carbon nanotubes functionalised with dihydroartemisinin drug in gas and solution phases. Phys. Chem. Liq. 2018, 56, 610−618. doi: 10.1080/00319104.2017.1367790
71. [71]
  Ketabi, S.; Rahmani, L. Carbon nanotube as a carrier in drug delivery system for carnosine dipeptide: a computer simulation study. Mater. Sci. Eng.: C 2017, 73, 173−181.
72. [72]
  Wadhwa, S.; Mumper, R. J. D-penicillamine and other low molecular weight thiols: review of anticancer effects and related mechanisms. Cancer Lett. 2013, 337, 8−21. doi: 10.1016/j.canlet.2013.05.027
73. [73]
  Peisach, J.; Blumberg, W. A mechanism for the action of penicillamine in the treatment of Wilson's disease. Mol. Pharmacol. 1969, 5, 200−209.
74. [74]
  Walshe, J. Penicillamine: the treatment of first choice for patients with Wilson's disease. Mov. Disord. 1999, 14, 545−550. doi: 10.1002/1531-8257(199907)14:4<545::AID-MDS1001>3.0.CO;2-U
75. [75]
  Metushi, I. G.; Zhu, X.; Uetrecht, J. D-penicillamine-induced granulomatous hepatitis in brown Norway rats. Mol. Cell. Biochem. 2014, 393, 229−235. doi: 10.1007/s11010-014-2065-8
76. [76]
  Camp, A. Penicillamine in the treatment of rheumatoid arthritis. J. Rheumatol. Suppl. 1980, 7, 103−106.
77. [77]
  Chandra, A.; Demirhan, I.; Arya, S.; Chandra, P. D‐Penicillamine inhibits transactivation of human immunodeficiency virus type‐1 (HIV‐1) LTR by transactivator protein. FEBS Lett. 1988, 236, 282−286. doi: 10.1016/0014-5793(88)80038-3
78. [78]
  Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Petersson, G. A.; Nakatsuji, H.; Li, X.; Caricato, M.; Marenich, A.; Bloino, J.; Janesko, B. G.; Gomperts, R.; Mennucci, B.; Hratchian, H. P.; Ortiz, J. V.; Izmaylov, A. F.; Sonnenberg, J. L.; Williams-Young, D.; Ding, F.; Lipparini, F.; Egidi, F.; Goings, J.; Peng, B.; Petrone, A.; Henderson, T.; Ranasinghe, D.; Zakrzewski, V. G.; Gao, J.; Rega, N.; Zheng, G.; Liang, W.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Throssell, K.; Montgomery, J. A. Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Keith, T.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Millam, J. M.; Klene, M.; Adamo, C.; Cammi, R.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Farkas, O.; Foresman, J. B.; Fox, D. J. Gaussian 09, Revision B. 01, Gaussian, Inc., Wallingford CT 2016.
79. [79]
  Tomasi, J.; Persico, M. Molecular interactions in solution: an overview of methods based on continuous distributions of the solvent. Chem. Rev. 1994, 94, 2027−2094. doi: 10.1021/cr00031a013
80. [80]
  Coitiño, E. L.; Tomasi, J.; Cammi, R. On the evaluation of the solvent polarization apparent charges in the polarizable continuum model: a new formulation. J. Comput. Chem. 1995, 16, 20−30. doi: 10.1002/jcc.540160103
81. [81]
  Parr, R. G.; Szentpaly, L. V.; Liu, S. Electrophilicity index. J. Am. Chem. Soc. 1999, 121, 1922−1924. doi: 10.1021/ja983494x
82. [82]
  Keith, T. A. AIMAll (Version 13.05. 06). TK Gristmill Software, Overland Park KS, USA 2013.
83. [83]
  Bader, R. F. A quantum theory of molecular structure and its applications. Chem. Rev. 1991, 91, 893−928. doi: 10.1021/cr00005a013
84. [84]
  Zhao, Y.; Truhlar, D. G. The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals. Theor. Chem. Acc. 2008, 120, 215−241. doi: 10.1007/s00214-007-0310-x
85. [85]
  Rozas, I.; Alkorta, I.; Elguero, J. Behavior of ylides containing N, O, and C atoms as hydrogen bond acceptors. J. Am. Chem. Soc. 2000, 122, 11154−11161. doi: 10.1021/ja0017864
86. [86]
  Espinosa, E.; Souhassou, M.; Lachekar, H.; Lecomte, C. Topological analysis of the electron density in hydrogen bonds. Acta Crystallogr. Sect. B: Struct. Sci. 1999, 55, 563−572. doi: 10.1107/S0108768199002128
1. [1]
  Tsegaye Tadesse Tsega , Jiantao Zai , Chin Wei Lai , Xin-Hao Li , Xuefeng Qian . Earth-abundant CuFeS2 nanocrystals@graphite felt electrode for high performance aqueous polysulfide/iodide redox flow batteries. Chinese Journal of Structural Chemistry, 2024, 43(1): 100192-100192. doi: 10.1016/j.cjsc.2023.100192
2. [2]
  Zhengyu Zhou , Huiqin Yao , Youlin Wu , Teng Li , Noritatsu Tsubaki , Zhiliang Jin . Synergistic Effect of Cu-Graphdiyne/Transition Bimetallic Tungstate Formed S-Scheme Heterojunction for Enhanced Photocatalytic Hydrogen Evolution. Acta Physico-Chimica Sinica, 2024, 40(10): 2312010-. doi: 10.3866/PKU.WHXB202312010
3. [3]
  Chaozheng He , Jia Wang , Ling Fu , Wei Wei . Nitric oxide assists nitrogen reduction reaction on 2D MBene: A theoretical study. Chinese Chemical Letters, 2024, 35(5): 109037-. doi: 10.1016/j.cclet.2023.109037
4. [4]
  Run-Han Li , Tian-Yi Dang , Wei Guan , Jiang Liu , Ya-Qian Lan , Zhong-Min Su . Evolution exploration and structure prediction of Keggin-type group IVB metal-oxo clusters. Chinese Chemical Letters, 2024, 35(5): 108805-. doi: 10.1016/j.cclet.2023.108805
5. [5]
  Ting-Ting Huang , Jin-Fa Chen , Juan Liu , Tai-Bao Wei , Hong Yao , Bingbing Shi , Qi Lin . A novel fused bi-macrocyclic host for sensitive detection of Cr₂O₇²⁻ based on enrichment effect. Chinese Chemical Letters, 2024, 35(7): 109281-. doi: 10.1016/j.cclet.2023.109281
6. [6]
  Dan-Ying Xing , Xiao-Dan Zhao , Chuan-Shu He , Bo Lai . Kinetic study and DFT calculation on the tetracycline abatement by peracetic acid. Chinese Chemical Letters, 2024, 35(9): 109436-. doi: 10.1016/j.cclet.2023.109436
7. [7]
  Songtao Cai , Liuying Wu , Yuan Li , Soham Samanta , Jinying Wang , Bing Liu , Feihu Wu , Kaitao Lai , Yingchao Liu , Junle Qu , Zhigang Yang . Intermolecular hydrogen-bonding as a robust tool toward significantly improving the photothermal conversion efficiency of a NIR-II squaraine dye. Chinese Chemical Letters, 2024, 35(4): 108599-. doi: 10.1016/j.cclet.2023.108599
8. [8]
  Keyang Li , Yanan Wang , Yatao Xu , Guohua Shi , Sixian Wei , Xue Zhang , Baomei Zhang , Qiang Jia , Huanhua Xu , Liangmin Yu , Jun Wu , Zhiyu He . Flash nanocomplexation (FNC): A new microvolume mixing method for nanomedicine formulation. Chinese Chemical Letters, 2024, 35(10): 109511-. doi: 10.1016/j.cclet.2024.109511
9. [9]
  Xin-Tong Zhao , Jin-Zhi Guo , Wen-Liang Li , Jing-Ping Zhang , Xing-Long Wu . Two-dimensional conjugated coordination polymer monolayer as anode material for lithium-ion batteries: A DFT study. Chinese Chemical Letters, 2024, 35(6): 108715-. doi: 10.1016/j.cclet.2023.108715
10. [10]
  Tao Ban , Xi-Yang Yu , Hai-Kuo Tian , Zheng-Qing Huang , Chun-Ran Chang . One-step conversion of methane and formaldehyde to ethanol over SA-FLP dual-active-site catalysts: A DFT study. Chinese Chemical Letters, 2024, 35(4): 108549-. doi: 10.1016/j.cclet.2023.108549
11. [11]
  Huijiao Fu , Peiqin Liang , Qianwen Chen , Yan Wang , Guang Li , Xuzi Cai , Shengtao Wang , Kun Chen , Shengying Shi , Zhiqiang Yu , Xuefeng Wang . COX-2 blocking therapy in cisplatin chemosensitization of ovarian cancer: An allicin-based nanomedicine approach. Chinese Chemical Letters, 2024, 35(8): 109241-. doi: 10.1016/j.cclet.2023.109241
12. [12]
  An Lu , Yuhao Guo , Yi Yan , Lin Zhai , Xiangyu Wang , Weiran Cao , Zijie Li , Zhixia Zhao , Yujie Shi , Yuanjun Zhu , Xiaoyan Liu , Huining He , Zhiyu Wang , Jian-Cheng Wang . Nanomedicine integrating the lipidic derivative of 5-fluorouracil, miriplatin and PD-L1 siRNA for enhancing tumor therapy. Chinese Chemical Letters, 2024, 35(6): 108928-. doi: 10.1016/j.cclet.2023.108928
13. [13]
  Yuanyi Zhou , Ke Ma , Jinfeng Liu , Zirun Zheng , Bo Hu , Yu Meng , Zhizhong Li , Mingshan Zhu . Is reactive oxygen species the only way for cancer inhibition over single atom nanomedicine? Autophagy regulation also works. Chinese Chemical Letters, 2024, 35(6): 109056-. doi: 10.1016/j.cclet.2023.109056
14. [14]
  Yating Zheng , Yulan Huang , Jing Luo , Xuqi Peng , Xiran Gui , Gang Liu , Yang Zhang . Supercritical fluid technology: A game-changer for biomacromolecular nanomedicine preparation and biomedical application. Chinese Chemical Letters, 2024, 35(7): 109169-. doi: 10.1016/j.cclet.2023.109169
15. [15]
  Jiaqi Huang , Renjiang Kong , Yanmei Li , Ni Yan , Yeyang Wu , Ziwen Qiu , Zhenming Lu , Xiaona Rao , Shiying Li , Hong Cheng . Feedback enhanced tumor targeting delivery of albumin-based nanomedicine to amplify photodynamic therapy by regulating AMPK signaling and inhibiting GSTs. Chinese Chemical Letters, 2024, 35(8): 109254-. doi: 10.1016/j.cclet.2023.109254
16. [16]
  Zongyi Huang , Cheng Guo , Quanxing Zheng , Hongliang Lu , Pengfei Ma , Zhengzhong Fang , Pengfei Sun , Xiaodong Yi , Zhou Chen . Efficient photocatalytic biomass-alcohol conversion with simultaneous hydrogen evolution over ultrathin 2D NiS/Ni-CdS photocatalyst. Chinese Chemical Letters, 2024, 35(7): 109580-. doi: 10.1016/j.cclet.2024.109580
17. [17]
  Xingyan Liu , Chaogang Jia , Guangmei Jiang , Chenghua Zhang , Mingzuo Chen , Xiaofei Zhao , Xiaocheng Zhang , Min Fu , Siqi Li , Jie Wu , Yiming Jia , Youzhou He . Single-atom Pd anchored in the porphyrin-center of ultrathin 2D-MOFs as the active center to enhance photocatalytic hydrogen-evolution and NO-removal. Chinese Chemical Letters, 2024, 35(9): 109455-. doi: 10.1016/j.cclet.2023.109455
18. [18]
  Zhenyang Lin . A classification scheme for inorganic cluster compounds based on their electronic structures and bonding characteristics. Chinese Journal of Structural Chemistry, 2024, 43(5): 100254-100254. doi: 10.1016/j.cjsc.2024.100254
19. [19]
  Xu-Hui Yue , Xiang-Wen Zhang , Hui-Min He , Lei Qiao , Zhong-Ming Sun . Synthesis, chemical bonding and reactivity of new medium-sized polyarsenides. Chinese Chemical Letters, 2024, 35(7): 108907-. doi: 10.1016/j.cclet.2023.108907
20. [20]
  Haojie Song , Laiyu Luo , Siyu Wang , Guo Zhang , Baojiang Jiang . Advances in poly(heptazine imide)/poly(triazine imide) photocatalyst. Chinese Chemical Letters, 2024, 35(10): 109347-. doi: 10.1016/j.cclet.2023.109347

Get Citation

PDF

XML

Metrics

PDF Downloads(2)
Abstract views(167)
HTML views(2)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142